The Prevalence and Impact of Substance Use Disorder and Treatment on Maternal Obstetric Experiences and Birth Outcomes Among Singleton Deliveries in Massachusetts
- PMID: 27832443
- PMCID: PMC5380534
- DOI: 10.1007/s10995-016-2190-y
The Prevalence and Impact of Substance Use Disorder and Treatment on Maternal Obstetric Experiences and Birth Outcomes Among Singleton Deliveries in Massachusetts
Abstract
Objectives Despite widely-known negative effects of substance use disorders (SUD) on women, children, and society, knowledge about population-based prevalence and impact of SUD and SUD treatment during the perinatal period is limited. Methods Population-based data from 375,851 singleton deliveries in Massachusetts 2003-2007 were drawn from a maternal-infant longitudinally-linked statewide dataset of vital statistics, hospital discharges (including emergency department (ED) visits), and SUD treatment records. Maternal SUD and SUD treatment were identified from 1-year pre-conception through delivery. We determined (1) the prevalence of SUD and SUD treatment; (2) the association of SUD with women's perinatal health service utilization, obstetric experiences, and birth outcomes; and (3) the association of SUD treatment with birth outcomes, using both bivariate and adjusted analyses. Results 5.5% of Massachusetts's deliveries between 2003 and 2007 occurred in mothers with SUD, but only 66% of them received SUD treatment pre-delivery. Women with SUD were poorer, less educated and had more health problems; utilized less prenatal care but more antenatal ED visits and hospitalizations, and had worse obstetric and birth outcomes. In adjusted analyses, SUD was associated with higher risk of prematurity (AOR 1.35, 95% CI 1.28-1.41) and low birth weight (LBW) (AOR 1.73, 95% CI 1.64-1.82). Women receiving SUD treatment had lower odds of prematurity (AOR 0.61, 95% CI 0.55-0.68) and LBW (AOR 0.54, 95% CI 0.49-0.61). Conclusions for Practice SUD treatment may improve perinatal outcomes among pregnant women with SUD, but many who need treatment don't receive it. Longitudinally-linked existing public health and programmatic records provide opportunities for states to monitor SUD identification and treatment.
Keywords: Linked health data systems; Perinatal health services utilization; Perinatal outcomes; Pregnancy; SUD treatment; Substance use disorder.
Similar articles
-
Maternal Substance Use Disorders and Infant Outcomes in the First Year of Life among Massachusetts Singletons, 2003-2010.J Pediatr. 2017 Dec;191:69-75. doi: 10.1016/j.jpeds.2017.08.045. Epub 2017 Oct 16. J Pediatr. 2017. PMID: 29050752
-
Treatment outcomes for substance use disorder among women of reproductive age in Massachusetts: a population-based approach.Drug Alcohol Depend. 2015 Feb 1;147:151-9. doi: 10.1016/j.drugalcdep.2014.11.025. Epub 2014 Dec 4. Drug Alcohol Depend. 2015. PMID: 25496707 Free PMC article.
-
A structural equation analysis on the relationship between maternal health services utilization and newborn health outcomes: a cross-sectional study in Eastern Uganda.BMC Pregnancy Childbirth. 2017 Mar 27;17(1):98. doi: 10.1186/s12884-017-1289-5. BMC Pregnancy Childbirth. 2017. PMID: 28347281 Free PMC article.
-
Maternal age ≥45 years and maternal and perinatal outcomes: a review of the evidence.Midwifery. 2013 May;29(5):479-89. doi: 10.1016/j.midw.2012.04.001. Epub 2012 Nov 16. Midwifery. 2013. PMID: 23159159 Review.
-
Multiple Pregnancy: Epidemiology and Association with Maternal and Perinatal Morbidity.Rev Bras Ginecol Obstet. 2018 Sep;40(9):554-562. doi: 10.1055/s-0038-1668117. Epub 2018 Sep 19. Rev Bras Ginecol Obstet. 2018. PMID: 30231294 Free PMC article. Review.
Cited by
-
A Novel 4D Ultrasound Parenting Intervention for Substance Using Pregnant Women in Finland: Participation in Obstetric Care, Fetal Drug Exposure, and Perinatal Outcomes in a Randomized Controlled Trial.Matern Child Health J. 2020 Jan;24(1):90-100. doi: 10.1007/s10995-019-02773-w. Matern Child Health J. 2020. PMID: 31250239 Free PMC article. Clinical Trial.
-
Maternal and Neonatal Outcomes in Women with Metabolic Syndrome and Substance Use Disorder.Life (Basel). 2023 Sep 19;13(9):1933. doi: 10.3390/life13091933. Life (Basel). 2023. PMID: 37763336 Free PMC article.
-
Principles of care for pregnant and parenting people with substance use disorder: the obstetrician gynecologist perspective.Front Pediatr. 2023 May 24;11:1045745. doi: 10.3389/fped.2023.1045745. eCollection 2023. Front Pediatr. 2023. PMID: 37292372 Free PMC article. Review.
-
Scoping Review of the Associations Between Perinatal Substance Use and Perinatal Depression and Anxiety.J Obstet Gynecol Neonatal Nurs. 2021 Jul;50(4):382-391. doi: 10.1016/j.jogn.2021.02.008. Epub 2021 Mar 25. J Obstet Gynecol Neonatal Nurs. 2021. PMID: 33773955 Free PMC article.
-
Management of the Cardiovascular Complications of Substance Use Disorders During Pregnancy.Curr Treat Options Cardiovasc Med. 2019 Nov 22;21(11):73. doi: 10.1007/s11936-019-0777-5. Curr Treat Options Cardiovasc Med. 2019. PMID: 31754867 Review.
References
-
- Bada HS, Das A, Bauer CR, Shanrakan S, Lester B, et al. Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstetrics and Gynecology. 2002;100:916–924. - PubMed
-
- Bernstein J, Bernstein E, Belanoff C, Cabral HJ, Babakhanlou-Chase H, et al. The association of injury with substance abuse disorder among women of reproductive age—an opportunity to address a major contributor to recurrent preventable ED visits? Academic Emergency Medicine. 2014;21:1459–1468. - PMC - PubMed
-
- Burns L, Mattick RP. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug and Alcohol Review. 2007;26(5):487–492. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical